March was National MS Education and Awareness Month. MS stands for Multiple sclerosis and is a neurological disorder. There are over 50 million Americans who are suffering with neurological disorders. These types of disorders are chronic and don’t always have treatments. But there has been recent studies that provide advances in therapeutic options for patients.
What is MS?
Multiple sclerosis involves the body’s immune system and central nervous system. “Multiple sclerosis (MS) involves an immune-mediated process in which an abnormal response of the body’s immune system is directed against the central nervous system (CNS), which is made up of the brain, spinal cord and optic nerves.” Those who suffer with MS usually have four disease courses that can be mild, moderate, or severe. It can be triggered by genetics and a combination of environmental factors.
There has not been any treatments for Multiple sclerosis until recently when advances in therapeutic options. The new medicines as treatments have fewer side effects and are more convenient for the patient. But there is still more research to be done on multiple sclerosis, especially the more rare forms.
At the moments, there are 40 different medicines that in development for patients. It can be an unpredictable disease because of how it disrupts the flow of information within the brain. “Biopharmaceutical researchers are working to leverage a growing understanding of the biology of MS and other neurological disorder in order to bring new medicines to patients. Last year, there were 420 medicines for neurological disorders in development by biopharmaceutical companies. All of these medicines are in human clinical trials or under review at the Food and Drug Administration.”
Advocate My Meds provides medication assistance to those who need it. If you need any help, don’t hesitate to call us at 877-596-1604